Clinical Trials in Atlanta

Showing 4321-4340 of 13,244 trials

Assessment of Macrophage Activation syndromE in STill's Disease

NCT06405152

Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics

Macrophage Activation SyndromeStill's Disease, Adult-OnsetStills Disease, Juvenile-Onset

Swedish Orphan Biovitrum75 participantsStarted Sep 2023

Los Angeles, California, United States • Atlanta, Georgia, United States • Cincinnati, Ohio, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

The purpose of this trial is to evaluate a CMV vaccine given to related donor/recipient pairs (donors prior to peripheral blood stem cell donation and CMV-seropositive recipients just before and after transplantation) and CMV-seropositive recipient-only subjects (related or unrelated) to determine incidence rates of CMV infection, disease, and other complications from immunosuppression and/or transplantation. The outcomes for the groups receiving CMV vaccine will be compared to the outcomes for the group that received the placebo vaccine to see if there is a clinical benefit. For this trial, donors and recipients must have matched HLA genotype (matched at 5/6 or 6/6 HLA loci).

Acute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more

Astellas Pharma Inc112 participantsStarted Jan 2006

Tucson, Arizona, United States • Duarte, California, United States • Denver, Colorado, United States +19 more locations

Assessment of Macrophage Activation syndromE in STill's Disease

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Find Trials by Condition in Atlanta

Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Vogelxo(R) ABPM Study in Hypogandal Men

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Milademetan in Advanced/Metastatic Solid Tumors

PK and Dose Escalation and Expansion Study of DST-2970

Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis